Posted on 2/5/21
Here's Why Pfizer's a Great Stock to Buy and Hold Now
If you've been hesitant to buy Pfizer (NYSE:PFE) stock recently, the market's reaction to the company's latest earnings release probably didn't improve your mood.Fourth-quarter earnings that . . .
Posted on 2/5/21
What's Behind Merck's Disappointing Q4 Results?
You might say that Merck (NYSE:MRK) is experiencing malaise. Its shares sank 10% in 2020 while many stocks soared. The big drugmaker hasn't gotten off to . . .
Posted on 2/4/21
Northern Westchester Hospital Opens State-of-the-art Electrophysiology Lab
Dr. Subbarao Choudry leads program Northern Westchester Hospital’s (NWH) has opened a state-of-the-art Electrophysiology Lab, offering specialized testing, expert diagnosis and advanced treatment for all types . . .
Posted on 2/4/21
Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, . . .
Posted on 2/4/21
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year . . .
Posted on 2/4/21
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its third quarter ended . . .
Posted on 2/4/21
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of . . .
Posted on 2/4/21
TYME Announces $100 Million Registered Direct Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), today announced that it has entered into definitive agreements with . . .
Posted on 2/4/21
Is It Too Late to Buy Pfizer Stock?
Anyone not following the market would probably think that Pfizer (NYSE:PFE) did well last year. With the publicity from a potentially pandemic-ending vaccine and agreements for . . .
Posted on 2/3/21
Why Pfizer's Q4 Results Simply Don't Matter Very Much
Pfizer (NYSE:PFE) achieved several huge milestones in the fourth quarter of 2020. The big drugmaker, along with its German partner BioNTech, reported outstanding data from a . . .
Posted on 2/3/21
Outlook Therapeutics Closes of $35.0 Million Public Offering of Common Stock
MONMOUTH JUNCTION, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg . . .
Posted on 2/3/21
Neuronetics Announces Closing of Public Offering
MALVERN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that . . .
Posted on 2/3/21
Krystal Biotech Announces Prices of Upsized $125 Million Public Offering of Common Stock
PITTSBURGH, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that it has . . .
Posted on 2/3/21
Geisinger and Children's Hospital of Philadelphia Announce Affiliation Agreement
Geisinger Janet Weis Children's Hospital and Children's Hospital of Philadelphia (CHOP) today announced an affiliation agreement that will increase access to and further advance the delivery . . .
Posted on 2/3/21
Krystal Biotech Proposes $100M Public Offering of Common Stock
PITTSBURGH--(BUSINESS WIRE)--Krystal Biotech Inc. (NASDAQ: KRYS), the leader in redosable gene therapies for rare diseases, today announced that it has commenced a $100 million underwritten public . . .
Posted on 2/2/21
Helius Medical Technologies Closes $11.0M Underwritten Public Offering
NEWTOWN, Pa., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), a neurotech company focused on neurological wellness, announced today the closing of . . .
Posted on 2/1/21
Quest Diagnostics Named One of 2021 "World's Most Admired Companies" by FORTUNE Magazine for Seventh Consecutive Year
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired . . .
Posted on 2/1/21
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company . . .
Posted on 2/1/21
Look Out, Pfizer and Moderna: Here Comes Novavax
Over the last couple of months, COVID-19 vaccines developed by Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE) along with its partner BioNTech (NASDAQ:BNTX) have been at the center . . .
Posted on 2/1/21
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Pharmaceutical companies Pfizer (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) are two of the biggest players in the race to vaccinate the world against COVID-19. Pfizer's vaccine, . . .
Posted on 2/1/21
Can Moderna and Pfizer Meet President Biden's Vaccine Goals?
If the goal of President Joe Biden is met, at least 100 million doses of vaccine will be delivered into people's arms by his 100th day . . .
Posted on 2/1/21
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Johnson & Johnson (NYSE:JNJ) released results today from the phase 3 clinical trial of its COVID-19 vaccine candidate, saying that the data showed it was 66% . . .
Posted on 2/1/21
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Which COVID-19 vaccine is the best? The correct answer is that it depends on which factor is most important to you.Comirnaty (BNT162b2), the vaccine developed by . . .
Posted on 1/29/21
VYNE Therapeutics Closes of $50 Million Registered Direct Offering of Common Stock
BRIDGEWATER, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that it has closed its previously announced registered direct offering of . . .
Posted on 1/29/21
Better Buy: Pfizer vs. BioNTech
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) together pulled off one of the greatest accomplishments in medical history by developing a safe and highly effective COVID-19 vaccine in . . .
Philadelphia
